Changes in platelet alpha-2-adrenoceptors in fibromyalgia: Effects of treatment with antidepressants

Neuropsychobiology

Volumn 40, Issue 3, 1999, Pages 129-133

  Maes, Michael ^a,b   Libbrecht, Isabelle ^a   Delmeire, Laure ^a   Lin, Aihua ^a   De Clerck, Luc ^d   Scharpe, Simon ^d   Janca, Aleksander ^c  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b VANDERBILT UNIVERSITY   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d University Department of Psychiatry ^*

Author keywords

2 receptor antagonists and agonists; Catecholamines; Depression; Fibromyalgia; Pain

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; PLACEBO; RAUWOLSCINE; SERTRALINE; THROMBOCYTE RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD PLATELETS; FEMALE; FIBROMYALGIA; HUMANS; KINETICS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC, ALPHA-2; SERTRALINE; YOHIMBINE;

EID: 0032884263     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026609     Document Type: Article

References (38)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.
2. Granges G, Zilko P, Littlejohn GO: Fibromyalgia syndrome: Assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 1994;21:523-529.
3. 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19: 104-109.
4. Siever LJ, Davis KL: Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 1985;142:1017-1031.
5. Maes M, Minner B, Suy E, Vandervorst C, Raus J: Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia. J Neural Transm 1991;85:195-210.
6. Potter WZ, Manji HK: Catecholamines in depression: An update. Clin Chem 1994;40:279-287.
7. Bennett RM, Clark SR, Campbell SM, Ingram SB, Burckhardt CS, Nelson DL, Porter JM: Symptoms of Raynaud's syndrome in patients with fibromyalgia. A study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet alpha-2-adrenergic receptors. Arthritis Rheum 1991;34:264-269.
8. Elam M, Johansson G, Wallin BG: Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992; 48:371-375.
9. Yunus MB, Daily JW, Aldag JC, Masi AT, Jobe PC: Plasma and urinary catecholamines in primary fibromyalgia: A controlled study. J Rheumatol 1992;19:95-97.
10. Russell IJ: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 1989;15:149-165.
11. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C: A randomized, double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39:1852-1859.
12. Spyraki C, Fibiger HC: Functional evidence for subsensitivity of noradrenergic α-2-receptors after chronic desipramine treatment. Life Sci 1980;27:1863-1867.
13. Svensson TH, Usdin T: Alpha-adrenoceptor mediated inhibition of brain noradrenergic neurons after acute and chronic treatment with tricyclic antidepressants; in Kopin IJ, Barchas J (eds): Catecholamines; Basic and Clinical Frontiers. Oxford, Pergamon Press, 1979, pp 672-674.
14. Sugrue MF: Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol Ther 1983;21:1-33.
15. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, American Psychiatric Association, 1987.
16. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview according to DSM-III-R. New York, American Press, 1990.
17. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-61.
18. Maes M, Lin A, Verkerk R, Delmeire L, Van Gastel A, Van der Planken M, Scharpé S: Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Neuropsychoparmacol, in press.
19. Stahl SM: Peripheral models for the study of neurotransmitter receptors in man. Psychopharmacol Bull 1985;21:663-671.
20. Hieble JP, Bondinell WE, Ruffolo RR: α- and β-adrenoceptors: From the gene to the clinic. I. Molecular biology and adrenoceptor classification. J Med Chem 1995;38:3415-3444.
21. 2-Autoreceptors in rabbit atria and kidney. Naunyn Schmiedebergs Arch Pharmacol 1995;352:31-42.
22. Kafka MS, Nurnberger JI, Siever L, Targum S, Uhde TW, Gershon ES: Alpha-2-adrenergic receptor function in patients with unipolar and bipolar affective disorders. J Affect Disord 1986;10:163-169.
23. 2-adrenergic receptors in depression. Arch Gen Psychiatry 1986;43:91-95.
24. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL: High plasma norepinephrine levels in patients with major affective disorders. Am J Psychiatry 1982;139:1315-1318.
25. Maes M, Vandewoude M, Schotte M, Martin M, Blockx P: Positive relationship between the catecholaminergic turnover and the DST results in depression. Psychol Med 1990;20:493-499.
26. Maes M, Meltzer HY, Suy E, Minner B, Calabrese J, Cosyns P: Sleep disorders and anxiety as symptom profiles of sympathoadrenal system hyperactivity in major depression. J Affect Disord 1993;27:197-207.
27. Rudorfer MV, Ross RS, Linnoila M, Sherer MA, Potter WZ: Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Arch Gen Psychiatry 1985;42:1186-1192.
28. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg M, Ashleigh EA, Castillo S, Peskind ER, Pascualy M, Halter JB: Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994;51:411-422.
29. Sato J, Perl ER: Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991;251:1608-1610.
30. Yeomans DC, Clark FM, Paice JA, Proudfit HK: Antinociception induced by electrical stimulation of spinally projection noradrenergic neurons in the A7 catecholamine cell group of the rat. Pain 1992;48:449-461.
31. Khasar SG, Green PG, Chou B, Levine JD: Peripheral nociceptive effects of alpha-2-adrenergic receptor agonists in the rat. Neuroscience 1995;66:427-432.
32. Millan MJ; Evidence that an alpha-2A-adrenoceptor subtype mediates antinociception in mice. Eur J Pharmacol 1992;14:355-356.
33. McQuay HJ: Pharmacological treatment of neuralgic and neuropathic pain. Cancer Surv 1988;7:141-159.
34. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J: Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993;79:1163-1169.
35. Lee Y-W, Yaksh TL: Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. Anesthesiology 1995;82:741-748.
36. Glynn C, O'Sullivan K: A double-blind randomized comparison of the effects of epidural clonidine, lignocaine and the combination of clonidine and lignocaine in patients with chronic pain. Pain 1995;64:337-343.
37. 2-adrenergic agonists. Anesthesiology 1991;74:766-771.
38. Maes M, Van Gastel A, Delmeire L, Meltzer HY: Decreased platelet alpha-2-adrenoceptor density in major depression: Effects of tricyclic antidepressants and fluoxetine. Biol Psychiatry, in press.